|Articles|July 15, 2004

"Nothing but the tooth": Dispelling myths about teething

Teething has long been the subject of superstition, speculation, and opinion, but little research. So, what do we know, and how can we best advise parents?

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Related Content

Jonathan Flyer, MD, highlights the LEAD initiative to increase pediatric lipid screenings

ByJonathan N. Flyer, MD

December 16th 2025

Rationale for supporting the birth dose of hepatitis B vaccine for all newborns

ByDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN

December 16th 2025

Mimi C. Lee, MD, PhD, breaks down GeneDx's ExomeDx and GenomeDx tests

ByMimi C. Lee, MD, PhD

December 15th 2025

FDA calls for improved retail recall compliance to protect infants and young children

ByMorgan Ebert, Managing Editor

December 15th 2025

Weekly review: Big week for pediatric FDA approvals

ByJoshua Fitch, Senior Editor

December 15th 2025

Latest CME

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

"Nothing but the tooth": Dispelling myths about teething

Newsletter

Related Content

Jonathan Flyer, MD, highlights the LEAD initiative to increase pediatric lipid screenings

Rationale for supporting the birth dose of hepatitis B vaccine for all newborns

Mimi C. Lee, MD, PhD, breaks down GeneDx's ExomeDx and GenomeDx tests

FDA calls for improved retail recall compliance to protect infants and young children

Weekly review: Big week for pediatric FDA approvals

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Meta-analysis finds vegetarian and vegan diets can support healthy growth in children

FDA calls for improved retail recall compliance to protect infants and young children

Rationale for supporting the birth dose of hepatitis B vaccine for all newborns

Mimi C. Lee, MD, PhD, breaks down GeneDx's ExomeDx and GenomeDx tests

FDA approves Nuzolvence (zoliflodacin) for treatment of uncomplicated urogenital gonorrhea in 12 years and up